Back
Y-mAbs Therapeutics Stock Price Chart
Sell
39
YMAB
Y-mAbs Therapeutics
Last Price:
12.13
Seasonality Move:
11.04%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and YMAB is experiencing selling pressure, which indicates risk of future bearish movement.
Y-mAbs Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.68 | Sell |
| 20-day SMA: | 14.82 | Sell |
| 50-day SMA: | 15.21 | Sell |
| 200-day SMA: | 9.54 | Buy |
| 8-day EMA: | 13.25 | Sell |
| 20-day EMA: | 14.31 | Sell |
| 50-day EMA: | 14.55 | Sell |
| 200-day EMA: | 11.24 | Buy |
Y-mAbs Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.73 | Sell |
| Relative Strength Index (14 RSI): | 33.38 | Sell |
| Chaikin Money Flow: | -156020 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.25 - 16.41) | Sell |
| Bollinger Bands (100): | (10.18 - 16.86) | Sell |
Y-mAbs Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Y-mAbs Therapeutics Stock
Is Y-mAbs Therapeutics Stock a Buy?
- Y-mAbs Therapeutics share price is 12.18 while YMAB 8-day simple moving average is 13.68, which is a Sell signal.
- The stock price of YMAB is 12.18 while Y-mAbs Therapeutics 20-day SMA is 14.82, which makes it a Sell.
- Y-mAbs Therapeutics 50-day simple moving average is 15.21 while YMAB share price is 12.18, making it a Sell technically.
- YMAB stock price is 12.18 and Y-mAbs Therapeutics 200-day simple moving average is 9.54, creating a Buy signal.
YMAB Technical Analysis vs Fundamental Analysis
Sell
39
Y-mAbs Therapeutics (YMAB)
is a Sell
Is Y-mAbs Therapeutics a Buy or a Sell?
-
Y-mAbs Therapeutics stock is rated a Sell
The current Y-mAbs Therapeutics [YMAB] share price is $12.18. The Score for YMAB is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Y-mAbs Therapeutics Stock Info
Market Cap:
534.49M
Price in USD:
12.18
Share Volume:
267.46K
Y-mAbs Therapeutics 52-Week Range
52-Week High:
20.90
52-Week Low:
4.60
Sell
39
Y-mAbs Therapeutics (YMAB)
is a Sell
Y-mAbs Therapeutics Share Price Forecast
-
What is the Y-mAbs Therapeutics stock price today?
The Y-mAbs Therapeutics stock price is 12.18 USD today. -
Will YMAB stock go up or go down?
Y-mAbs Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Y-mAbs Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Y-mAbs Therapeutics is overvalued.
Is Y-mAbs Therapeutics Stock a Buy?
- Y-mAbs Therapeutics share price is 12.18 while YMAB 8-day exponential moving average is 13.25, which is a Sell signal.
- The stock price of YMAB is 12.18 while Y-mAbs Therapeutics 20-day EMA is 14.31, which makes it a Sell.
- Y-mAbs Therapeutics 50-day exponential moving average is 14.55 while YMAB share price is 12.18, making it a Sell technically.
- YMAB stock price is 12.18 and Y-mAbs Therapeutics 200-day simple moving average is 11.24, creating a Buy signal.
Fundamental Analysis of Y-mAbs Therapeutics
Is Y-mAbs Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.07 per share, an increase this year of $0.22 per share, and an increase next year of $0.29 per share.
Technical Analysis of Y-mAbs Therapeutics
Should I short Y-mAbs Therapeutics stock?
- YMAB Moving Average Covergence Divergence (MACD) indicator is -0.73, suggesting Y-mAbs Therapeutics is a Sell
- Y-mAbs Therapeutics Relative Strength Index (RSI) is 33.38, which suggest Y-mAbs Therapeutics is oversold
- The Bollinger Bands (25) for Y-mAbs Therapeutics is (13.25 - 16.41), which suggest Y-mAbs Therapeutics is a Sell
- The Bollinger Bands (100) for Y-mAbs Therapeutics is (10.18 - 16.86), which suggest Y-mAbs Therapeutics is a Sell
* Y-mAbs Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.